Japan To Start Clinical Study On Lilly's Gemzar For Ovarian Cancer
This article was originally published in PharmAsia News
Executive SummaryMinister of Health, Labor and Welfare Akira Nagatsuma said the ministry is working with Eli Lilly to start a clinical study on Gemzar (gemcitabine) for ovarian cancer from April
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.